Improving Rheumatoid Arthritis Care: Understanding the Latest Approvals and Treatment Strategies
Rheumatoid arthritis (RA) persists as an inflammatory condition with substantial morbidity. While the wide variety of RA treatment options continues to grow (two additional agents were approved in the last two years), rheumatologists remain challenged with staying up-to-date on the latest clinical trial data. Other gaps in RA care relate to the lack of treat-to-target (T2T) goals and shared decision-making (SDM), both of which are now important components of modern RA management. To best address these knowledge and practice gaps, it is critical that rheumatologists partake in continuing education.
“Improving Rheumatoid Arthritis Care: Understanding the Latest Approvals and Treatment Strategies,” will provide rheumatologists with current evidence regarding treatment goals and therapies for RA as well as strategies for effectively communicating with patients about their RA care.
The intended audience for this activity is rheumatologists, the main care providers for patients with RA.
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
At the conclusion of this education, participants should be able to:
- Implement strategies to facilitate shared decision-making to establish treat-to-target (T2T) goals
- Evaluate the safety and efficacy data for newer RA agents
- Incorporate the latest RA therapies into appropriate treatment plans
Donald Kimpel, MD, MA
Rheumatology & Immunology
Associate Professor of Medicine
University of Virginia
Donald L. Kimpel, MD, MA is an Associate Professor of Medicine in the Division of Clinical Rheumatology at the University of Virginia in Charlottesville, VA. He earned his medical doctorate from Ohio State University before completing his residency in internal medicine at the University of Maryland. He then completed a fellowship in rheumatology at the University of North Carolina at Chapel Hill.
Board‐certified in internal medicine and rheumatology, Dr. Kimpel manages patients with osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus (SLE), vasculitis, and other rheumatology disorders in clinical practice. His research interests include understanding the pathogenesis of autoimmune diseases and how inflammatory cells reach their targets.
Dr. Kimpel is Program Director for the Rheumatology Fellowship Training Program. In addition to providing education on clinical skills, his teaching interests include clinical decision-making and the science of learning. He has received several awards, including the 2016 Bedside Manner Award from Our Health Magazine and inclusions on the listings of the “Best Doctors in America” and “America’s Top Physicians.”
Brian F. Mandell, MD, PhD, FACR, MAC
Professor and Chairman of Academic Medicine
Deptartment of Rheumatologic Disease
Cleveland Clinic Lerner College of Medicine
Brian F. Mandell, MD, PhD, FACR, MACP is Professor and Chairman of Academic Medicine and a Senior Staff Physician in Rheumatology and Immunologic Diseases, Center for Vasculitis Care and Research at the Cleveland Clinic.
Dr. Mandell joined the Cleveland Clinic in 1993 following a faculty appointment at the Hospital of the University of Pennsylvania and Chief of Rheumatology at the Graduate Hospital. He previously earned a BA in Biology and a PhD in Physiology and Biophysics from Washington University, St. Louis, and then a Medical Degree from New York University School of Medicine. He trained in medicine and rheumatology at the University of Pennsylvania. He is board certified in Internal medicine and Rheumatology. He served as interim Director of Inflammation Research and Exploratory Clinical Pharmacology at CIBA Pharmaceuticals.
He is currently Editor-in-Chief of the Cleveland Clinic Journal of Medicine and is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He previously served as the Director of the Cleveland Clinic Internal Medicine Residency Program’s Scholarly Activity Program and the Medicine Humanities Program. He is a graduate of the Stanford Faculty Development Program in clinical teaching. He completed a term as member of the Cleveland Clinic’s Board of Governors, and has participated in or chaired many clinical/administrative and academic task forces at the Clinic.
DISCLOSURES OF CONFLICTS OF INTEREST
This educational activity has been produced in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Nursing Continuing Professional Development (NCPD) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Steering Committee Disclosures
The steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Donald L. Kimpel, MD, MA: Nothing to disclose
Brian F. Mandell, MD, PhD, FACR, MACP: Consultant/Independent Contractor: Genentech, Merck
Michael York, MD CME Course Director: Nothing to disclose
Non-faculty Content Contributors
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Chad Williamson, MS, MBA, CMMP; Elizabeth Drury; Natalie Sanfratello, MPH: Nothing to disclose
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN DESIGNATION STATEMENT
Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: [email protected].
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through BUSM’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
MOC APPROVAL STATEMENT
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Improving Rheumatoid Arthritis Care: Understanding the Latest Approvals and Treatment Strategies has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II CME Activity
- 1.00 MOC
- 1.00 MOC II
- 1.00 AMA PRA Category 1 Credit™
This course is offered through Rockpointe.
To take this course you will be redirected to Rockpointe's website. You must login or create an account with Rockpointe in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!